<DOC>
	<DOCNO>NCT00000379</DOCNO>
	<brief_summary>The purpose study compare two treatment post-traumatic stress disorder ( PTSD ) : fluoxetine ( antidepressant ) Eye Movement Desensitization Reprocessing ( EMDR , psychological treatment patient lead memory traumatic experience order heal him/herself ) . There variety therapy use treat PTSD , effectiveness medication alone vs exposure treatment , EMDR , test . Patients assign randomly ( like toss coin ) one three group 8 week treatment . Group 1 receive fluoxetine ; Group 2 receive EMDR ; Group 3 receive inactive placebo . Patients stop treatment evaluation , include psychological test , time treatment stop , 8 week later , 6 month . An individual may eligible study he/she : Has PTSD 18 65 year old .</brief_summary>
	<brief_title>Fluoxetine v EMDR Treat Post-Traumatic Stress Disorder ( PTSD )</brief_title>
	<detailed_description>To compare short-term long-term efficacy two different treatment approach widespread use clinical setting treat patient post-traumatic stress disorder ( PTSD ) : fluoxetine ( act directly biological system ) vs psychological treatment , Eye Movement Desensitization Reprocessing ( EMDR ) . To clarify : 1 ) differential treatment effect different treatment modality ; 2 ) whether symptom improvement accompany change pathophysiology ; 3 ) long-term effectiveness treatment . In recent year variety treatment approach show effective treatment PTSD . These include prolonged exposure therapy ( PE ) , stress inoculation training ( SIT ) , EMDR psychopharmacological treatment serotonin re-uptake blocker . While PE compare SIT study currently way compare cognitive-behavioral treatment EMDR , study yet compare relative merit pharmacotherapy alone vs exposure treatment . While commonly hold , order recover , people PTSD need `` process '' traumatic memory , treatment involve process traumatic memory ( SIT pharmacotherapy ) may effective . In clinical practice , many patient PTSD appear effectively treated pharmacological agent alone , without trauma-focused therapy . Patients randomly assign one three condition : 1 ) double-blind psychopharmacological treatment ( fluoxetine ) ; 2 ) manualized treatment focus `` process '' traumatic memory ( EMDR ) ; 3 ) placebo control group . After 8 week active treatment , subject evaluate , cease treatment , assess another 8 week 6 month order evaluate long-term effect . Training raters remain blind subject ' treatment condition throughout study . Treatment outcome assess multi-modal psychological biological assessment battery include : 1 ) standard psychological test PTSD ( CAPS ) ; 2 ) neuroendocrine function ( cortisol ) ; 3 ) psychophysiological response traumatic script ( pre-post change heart social occupational functioning ) . Treatment adherence monitor throughout study .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>Patients must : PostTraumatic Stress Disorder ( PTSD ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Adult</keyword>
	<keyword>Comparative Study</keyword>
	<keyword>Desensitization , Psychologic</keyword>
	<keyword>Eye Movements</keyword>
	<keyword>Female</keyword>
	<keyword>Fluoxetine</keyword>
	<keyword>Human</keyword>
	<keyword>Male</keyword>
	<keyword>Placebos</keyword>
	<keyword>Stress Disorders , Post-Traumatic</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>Desensitization , Psychologic -- *methods</keyword>
	<keyword>Fluoxetine -- *therapeutic use</keyword>
	<keyword>Stress Disorders , Post-Traumatic -- *therapy</keyword>
	<keyword>Stress Disorders , Post-Traumatic -- drug therapy</keyword>
</DOC>